Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShort-Term Debt issuancesShort-Term Debt repayments
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Free Cash Flow (2020 - 2025)

Bio Essence has reported Free Cash Flow over the past 6 years, most recently at $1.2 million for Q4 2025.

  • For Q4 2025, Free Cash Flow rose 182.69% year-over-year to $1.2 million; the TTM value through Dec 2025 reached $1.6 million, up 145.34%, while the annual FY2025 figure was $1.6 million, 145.34% up from the prior year.
  • Free Cash Flow for Q4 2025 was $1.2 million at Bio Essence, up from $186973.0 in the prior quarter.
  • Over five years, Free Cash Flow peaked at $1.2 million in Q4 2025 and troughed at -$830883.0 in Q2 2021.
  • A 5-year average of -$46758.0 and a median of -$57188.5 in 2022 define the central range for Free Cash Flow.
  • Biggest five-year swings in Free Cash Flow: plummeted 937.46% in 2023 and later skyrocketed 998.65% in 2025.
  • Year by year, Free Cash Flow stood at -$232412.0 in 2021, then skyrocketed by 65.82% to -$79432.0 in 2022, then plummeted by 937.46% to -$824074.0 in 2023, then skyrocketed by 153.27% to $439018.0 in 2024, then skyrocketed by 182.69% to $1.2 million in 2025.
  • Business Quant data shows Free Cash Flow for BIOE at $1.2 million in Q4 2025, $186973.0 in Q3 2025, and $167797.0 in Q2 2025.